Japan to undertake iPS cell trials in coming years

06/25/2009 | Breitbart.com

Japan reportedly is planning within five years to conduct clinical trials on induced pluripotent stem cells aimed at producing retinal pigment epithelial cells to cure age-related macular degeneration and hematopoietic stem cells to treat blood conditions, among other treatments. The plan also calls for the creation of an iPS cell bank within two years.

View Full Article in:

Breitbart.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC